ENTA vs PG · rev $65.3M vs P/E 25, rev $84.28B
Enanta Pharmaceuticals Inc (ENTA) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ENTA currently screens at market cap $328.0M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ENTA and PG stock pages for the full models.
Not investment advice.